Ontology highlight
ABSTRACT: Background
Diosmectite, a natural colloidal clay, has been used worldwide for a number of approved indications, including the treatment of chronic functional diarrhea. Here, we used high-resolution whole metagenome shotgun sequencing to assess the impact of a 5 weeks administration of diosmectite (3 g/sachet, 3 sachets/day) on the fecal microbiota of 35 adults with functional chronic diarrhea.Results
Gut microbiota was not impacted by diosmectite administration. In particular, richness remained stable and no microbial species displayed a significant evolution. Segregating patients either by diosmectite response (non responder, early responder, late responder) or by nationality (Great-Britain or Netherlands) yielded the same results.Conclusion
We concluded that no microbiota-related physiological alterations are expected upon long-term treatment with diosmectite.Trial registration
Clinicaltrials.gov NCT03045926.
SUBMITTER: Da Silva K
PROVIDER: S-EPMC8840705 | biostudies-literature | 2022 Feb
REPOSITORIES: biostudies-literature
Da Silva Kévin K Guilly Susie S Thirion Florence F Le Chatelier Emmanuelle E Pons Nicolas N Roume Hugo H Quinquis Benoît B Ehrlich Stanislav D SD Bekkat Nassima N Mathiex-Fortunet Hélène H Sokol Harry H Doré Joël J
BMC microbiology 20220212 1
<h4>Background</h4>Diosmectite, a natural colloidal clay, has been used worldwide for a number of approved indications, including the treatment of chronic functional diarrhea. Here, we used high-resolution whole metagenome shotgun sequencing to assess the impact of a 5 weeks administration of diosmectite (3 g/sachet, 3 sachets/day) on the fecal microbiota of 35 adults with functional chronic diarrhea.<h4>Results</h4>Gut microbiota was not impacted by diosmectite administration. In particular, ri ...[more]